Sumitomo Pharma Co., Ltd. (TYO:4506)

Sumitomo Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	845,374	824,574	289,624	158,122	321,807	479,930
Market Cap Growth	28.65%	184.70%	83.17%	-50.86%	-32.95%	-37.31%
Enterprise Value	929,392	1,026,205	578,654	533,549	368,625	618,328
Last Close Price	1884.50	2075.50	729.00	398.00	810.00	1180.81

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	6.81	7.72	12.26	-	-	8.51
Forward PE	8.67	9.45	19.16	20.73	20.73	11.10
PS Ratio	1.78	1.82	0.73	0.50	0.58	0.86
PB Ratio	2.07	2.82	1.71	1.01	0.79	0.71
P/TBV Ratio	22.96	-	-	-	-	34.15
P/FCF Ratio	13.93	12.29	36.19	-	92.74	20.09
P/OCF Ratio	13.11	11.50	17.55	-	26.96	15.36
PEG Ratio	-	0.39	1.02	1.02	1.02	0.46

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	1.96	2.26	1.45	1.70	0.66	1.10
EV/EBITDA Ratio	12.96	14.27	14.10	-	-	6.29
EV/EBIT Ratio	17.58	19.43	32.56	-	-	10.31
EV/FCF Ratio	15.32	15.29	72.31	-	106.23	25.88

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.39	0.77	1.85	2.74	0.85	0.42
Debt / EBITDA Ratio	2.35	3.12	7.66	-	-	2.89
Debt / FCF Ratio	2.65	3.34	39.27	-	99.82	11.91
Net Debt / Equity Ratio	0.21	0.62	1.64	2.55	0.50	0.12
Net Debt / EBITDA Ratio	1.23	2.50	6.77	-1.26	-2.38	0.83
Net Debt / FCF Ratio	1.39	2.68	34.74	-1.58	58.47	3.41
Asset Turnover	0.60	0.59	0.48	0.31	0.46	0.43
Inventory Turnover	2.52	2.15	1.45	1.21	1.85	1.64
Quick Ratio	0.84	0.66	0.50	0.25	0.65	1.27
Current Ratio	1.21	1.03	1.05	0.52	1.03	1.79
Return on Equity (ROE)	38.53%	46.27%	14.52%	-111.89%	-17.90%	6.14%
Return on Assets (ROA)	3.92%	4.27%	1.35%	-21.74%	-6.46%	2.86%
Return on Invested Capital (ROIC)	10.26%	11.48%	3.55%	-60.99%	-18.52%	3.91%
Return on Capital Employed (ROCE)	8.50%	9.90%	3.50%	-90.60%	-16.50%	5.80%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	14.69%	12.96%	8.16%	-199.19%	-23.15%	11.75%
FCF Yield	7.18%	8.14%	2.76%	-159.79%	1.08%	4.98%
Dividend Yield	-	-	-	-	2.59%	2.32%
Payout Ratio	0.00%	0.00%	0.01%	-	-	19.72%
Buyback Yield / Dilution	-2.41%	0.00%	0.00%	0.00%	0.00%	0.00%
Total Shareholder Return	-2.41%	-	-	-	2.59%	2.32%

Data Source: S&P Global Market Intelligence Last updated: Jul 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error